Why Multiplexing Will Continue to Grow

Doing more with less is a very common challenge faced by many industries today. It is particularly important in the healthcare market overall, but especially in clinical laboratories, where costs are continually rising as laboratory resources are shrinking. Clinical diagnostics represent an important, rapidly growing, and advancing market segment uniquely positioned to address these healthcare challenges. Data indicate approximately 60 to 70 percent of all patient diagnoses and medical treatments are based on laboratory test results. As laboratories look for ways to increase productivity and reduce costs, more laboratories are incorporating productivity-enhancing multiplexing technology that allows simultaneous detection of multiple analytes from one sample.

Given current healthcare constraints, it is easy to see why multiplexing, which enables lab professionals to do more work with less labor, is becoming an established gold-standard. A good example of how innovative multiplexing technology can enable clinical labs to make the most of their precious resources is our NeoPlex4® Assay and NeoPlex® System, a fully automated, walk away sample processing instrument, which recently received CE marking.

Thanks to the efforts of dedicated and hardworking staff, companies like ours continue to make a significant contribution that benefits patients and laboratories through innovation. In addition, the continued identification and validation of novel genes and biomarkers is certain to drive development and introduction of new assays and instruments in this market for several years to come.

As the CEO of a company that serves the clinical diagnostic community, I believe the key factors that will fuel the continued growth of the industry include:

  • Ongoing investment in the discovery of new biomarkers that advance our understanding about the complexity and treatment of disease
  • Commitment to providing innovative technologies that help medical laboratory professionals improve patient outcomes and reduce overall healthcare costs, by replacing legacy methods with new standards of care
  • Establishing creative strategic partnerships between scientists, healthcare professionals and private companies that will continue to advance state-of-the-art science and new thinking
  • Strengthening and building initiatives in healthcare and regulatory reform that maintain and improve patient outcomes and safety by effectively using advanced technology

We are pleased to be a significant contributor to the innovation and expansion of this important industry and we remain committed to continuing to develop groundbreaking products that improve the health, safety and quality of life for people around the world.